Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology.

[1]  A. Órfão,et al.  Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis. , 2016, The Journal of allergy and clinical immunology.

[2]  K. Sotlar,et al.  Large maculopapular cutaneous lesions are associated with favorable outcome in childhood-onset mastocytosis. , 2015, The Journal of allergy and clinical immunology.

[3]  L. Scott,et al.  Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis. , 2015, The Journal of allergy and clinical immunology.

[4]  C. Heybeli.  Mast Cells, Mastocytosis, and Related Disorders. , 2015, The New England journal of medicine.

[5]  C. Bodemer,et al.  Paediatric mastocytosis: a systematic review of 1747 cases , 2015, The British journal of dermatology.

[6]  P. Dubreuil,et al.  Molecular basis of mast cell disease. , 2015, Molecular immunology.

[7]  E. Jassem,et al.  Does the Aberrant Expression of CD2 and CD25 by Skin Mast Cells Truly Correlate with Systemic Involvement in Patients Presenting with Mastocytosis in the Skin? , 2014, International Archives of Allergy and Immunology.

[8]  D. Metcalfe,et al.  Telangiectasia macularis eruptiva perstans or highly vascularized urticaria pigmentosa? , 2014, The journal of allergy and clinical immunology. In practice.

[9]  P. Valent.  Risk factors and management of severe life‐threatening anaphylaxis in patients with clonal mast cell disorders , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[10]  G. Bandara,et al.  Mastocytosis associated with a rare germline KIT K509I mutation displays a well-differentiated mast cell phenotype. , 2014, The Journal of allergy and clinical immunology.

[11]  T. Zuberbier,et al.  The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.

[12]  A. Órfão,et al.  Anaphylaxis as a Clinical Manifestation of Clonal Mast Cell Disorders , 2014, Current Allergy and Asthma Reports.

[13]  P. Valent,et al.  Diagnostic criteria and classification of mastocytosis in 2014. , 2014, Immunology and allergy clinics of North America.

[14]  L. Delong,et al.  Severity of Cutaneous Findings Predict the Presence of Systemic Symptoms in Pediatric Maculopapular Cutaneous Mastocytosis , 2014, Pediatric dermatology.

[15]  C. Grattan,et al.  TMEP or not TMEP: That is the question. , 2014, Journal of the American Academy of Dermatology.

[16]  J. Yin,et al.  A new germline mutation in KIT associated with diffuse cutaneous mastocytosis in a Chinese family , 2014, Clinical and experimental dermatology.

[17]  B. Galen,et al.  Darier's sign in mastocytosis. , 2014, Blood.

[18]  G. Nilsson,et al.  High prevalence of anaphylaxis in patients with systemic mastocytosis – a single‐centre experience , 2014, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[19]  A. Bellizzi,et al.  Identification of KIT activating mutations in paediatric solitary mastocytoma , 2014, Histopathology.

[20]  T. Haferlach,et al.  Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis , 2014, Modern Pathology.

[21]  L. Sánchez-Muñoz,et al.  Patterns of Expression of CD25 and CD30 on Skin Mast Cells in Pediatric Mastocytosis , 2014 .

[22]  A. Patrizi,et al.  Diffuse cutaneous mastocytosis: a heterogeneous disease , 2013, Archives of Disease in Childhood.

[23]  P. Valent.  Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology. , 2013, American journal of cancer research.

[24]  B. Wawrzycki,et al.  Diffuse cutaneous bullous mastocytosis in a newborn , 2013, Dermatologic therapy.

[25]  P. Dubreuil,et al.  Mast cell leukemia. , 2013, Blood.

[26]  B. Nedoszytko,et al.  Clinical aspects of paediatric mastocytosis: a review of 101 cases , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[27]  R. Büttner,et al.  Mast cells play a protumorigenic role in primary cutaneous lymphoma. , 2012, Blood.

[28]  I. Alvarez-Twose,et al.  Childhood mastocytosis , 2012, Current opinion in pediatrics.

[29]  B. Nedoszytko,et al.  State of the art paper Mastocytosis in children and adults: clinical disease heterogeneity , 2012 .

[30]  B. Nedoszytko,et al.  Mastocytosis in children and adults: clinical disease heterogeneity , 2012, Archives of medical science : AMS.

[31]  A. Órfão,et al.  Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis , 2012, Allergy.

[32]  A. Órfão,et al.  Complete response after imatinib mesylate therapy in a patient with well-differentiated systemic mastocytosis. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  M. Parmar,et al.  Flexible trial design in practice: Dropping and adding arms in STAMPEDE (MRC PR08, CRUK/06/019)-A multiarm, multistage randomized controlled trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  W. Biernat,et al.  Diffuse cutaneous mastocytosis: analysis of 10 cases and a brief review of the literature , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[35]  C. E. Pedreira,et al.  Evaluation of the WHO criteria for the classification of patients with mastocytosis , 2011, Modern Pathology.

[36]  F. Bertucci,et al.  Pediatric mastocytosis-associated KIT extracellular domain mutations exhibit different functional and signaling properties compared with KIT-phosphotransferase domain mutations. , 2010, Blood.

[37]  A. Órfão,et al.  Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes. , 2010, The Journal of allergy and clinical immunology.

[38]  L. Thomas,et al.  Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. , 2010, The Journal of investigative dermatology.

[39]  M. Djokic.  Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors , 2010 .

[40]  D. Metcalfe,et al.  Pediatric‐onset mastocytosis: A long term clinical follow‐up and correlation with bone marrow histopathology , 2009, Pediatric blood & cancer.

[41]  E. Crivellato,et al.  Co-localization of tryptase and cathepsin-G in mast cells in cutaneous mastocytosis. , 2009, Cancer letters.

[42]  Olivier Hermine,et al.  Phenotypic and Genotypic Characteristics of Mastocytosis According to the Age of Onset , 2008, PloS one.

[43]  N. Webber,et al.  How reliable is blood tryptase as a marker of systemic disease in an infant with cutaneous mastocytomas? , 2008, Clinical and experimental dermatology.

[44]  J. Ring,et al.  Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients , 2008, Allergy.

[45]  J. Hornick,et al.  CD25 Expression on Cutaneous Mast Cells From Adult Patients Presenting With Urticaria Pigmentosa is Predictive of Systemic Mastocytosis , 2008, The American journal of surgical pathology.

[46]  F. Sim,et al.  Mastocytosis (Mast Cell Disease) , 2008 .

[47]  M. Dieguez,et al.  Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA) , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[48]  M. Triggiani,et al.  Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria , 2007, European journal of clinical investigation.

[49]  柳堀 浩克.  c-kit mutations in patients with childhood-onset mastocytosis and genotype-phenotype correlation , 2006 .

[50]  E. Wardelmann,et al.  Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis. , 2005, Gastroenterology.

[51]  D. Ben-Amitai,et al.  Pediatric cutaneous mastocytosis: a review of 180 patients. , 2005, The Israel Medical Association journal : IMAJ.

[52]  A. Burden,et al.  A germline mutation in KIT in familial diffuse cutaneous mastocytosis , 2004, Journal of Medical Genetics.

[53]  A. Órfão,et al.  Well-differentiated systemic mastocytosis: A new disease variant with mature mast cell phenotype and lack of codon 816 c-Kit mutations , 2004 .

[54]  D. Metcalfe,et al.  Systemic mastocytosis. , 2004, Annual review of medicine.

[55]  D. Metcalfe,et al.  Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. , 2003, Journal of the American Academy of Dermatology.

[56]  M. Maurer,et al.  Pattern analysis of human cutaneous mast cell populations by total body surface mapping , 2003, The British journal of dermatology.

[57]  C. Skrabs.  Darier sign: a historical note. , 2002, Archives of dermatology.

[58]  L. Scott,et al.  Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease. , 2002, Archives of dermatology.

[59]  P. Valent,et al.  Response to the letter of Dr. Karin Hartmann and Dr. Beate M. Henz , 2002 .

[60]  K. Hartmann,et al.  Classification of cutaneous mastocytosis: a modified consensus proposal. , 2002, Leukemia research.

[61]  D. Metcalfe,et al.  Paediatric mastocytosis , 2002, Archives of disease in childhood.

[62]  K. Hartmann,et al.  Cutaneous Mastocytosis – Clinical Heterogeneity , 2002, International Archives of Allergy and Immunology.

[63]  L. Scott,et al.  Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase. , 2002, The Journal of allergy and clinical immunology.

[64]  K. Wolff,et al.  Clinical and histopathological aspects of cutaneous mastocytosis. , 2001, Leukemia research.

[65]  K. Lennert,et al.  Diagnostic criteria and classification of mastocytosis: a consensus proposal. , 2001, Leukemia research.

[66]  K. Hartmann,et al.  Mastocytosis: recent advances in defining the disease , 2001, The British journal of dermatology.

[67]  S. Goerdt,et al.  Nodular and bullous cutaneous mastocytosis of the xanthelasmoid type: case report , 2001, The British journal of dermatology.

[68]  N. Soter.  Mastocytosis and the skin. , 2000, Hematology/oncology clinics of North America.

[69]  N. Sepp,et al.  Comparison of Genetic and Immunohistochemical Findings in Childhood and Adult Onset Urticaria Pigmentosa , 1999, International Archives of Allergy and Immunology.

[70]  D. Metcalfe,et al.  Pediatric mastocytosis. , 1994, Annals of allergy.

[71]  E. Jordá,et al.  Xanthelasmoid Mastocytosis , 1991, Pediatric dermatology.

[72]  N. Soter.  The skin in mastocytosis. , 1991, The Journal of investigative dermatology.

[73]  D. Metcalfe.  Classification and diagnosis of mastocytosis: current status. , 1991, The Journal of investigative dermatology.

[74]  D. Metcalfe,et al.  Mast cells in cutaneous mastocytosis: accumulation of the MCTC type , 1990, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[75]  E. Bergstralh,et al.  Systemic Mast Cell Disease: ANALYSIS OF 58 CASES AND LITERATURE REVIEW , 1988, Medicine.

[76]  D. Metcalfe,et al.  A survey of the number and distribution of mast cells in the skin of patients with mast cell disorders. , 1988, The Journal of allergy and clinical immunology.

[77]  K. Lennert,et al.  Tissue mast cells in health and disease. , 1985, Pathology, research and practice.

[78]  H. Behrendt,et al.  Urticaria pigmentosa: clinical picture and response to oral disodium cromoglycate , 1981, The British journal of dermatology.

[79]  F. Sagher,et al.  Chapter V Incidence of Mastocytosis , 1967 .

[80]  R. Caplan.  The natural course of urticaria pigmentosa. Analysis and follow-up of 112 cases. , 1963, Archives of dermatology.